☆ 4.7 Article

CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex

Jialin Mo et al.

Summary: The study identifies SSRP1 as a crucial gene that is directly induced by EWSR1::FLI1 and forms an oncogenic positive feedback loop with it, promoting EwS oncogenesis. The FACT inhibitor CBL0137 effectively disrupts this loop, providing a novel therapeutic strategy for treating EwS.

ONCOGENE (2023)

Add to Collection

Article Oncology

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma

Jiaquan Luo et al.

Summary: Osteosarcoma is a highly malignant bone tumor that is difficult to treat, especially in children and adolescents. KIAA1429, a component of the m6A complex, plays a crucial role in tumorigenesis. However, the exact mechanism of KIAA1429 in regulating osteosarcoma cell identity is still unclear and requires further investigation.

JOURNAL OF BONE ONCOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner

Ling Ma et al.

Summary: The study showed that KIAA1429 was significantly upregulated in colorectal cancer tissues and its high expression was associated with shorter overall survival. KIAA1429 promoted colorectal cancer cell proliferation by negatively regulating WEE1 expression, indicating its potential as a prognostic marker for CRC.

ONCOGENE (2022)

Add to Collection

Article Multidisciplinary Sciences

Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing's sarcoma

Jie Jiang et al.

Summary: This study explores the prognostic biomarkers of m6A-related genes in Ewing's sarcoma. Prognostic models were constructed using data from two datasets and validated using laboratory methods. The study also investigated immune cell composition, drug sensitivity, and gene expression, and confirmed the results through immunohistochemical staining and qRT-PCR. The findings suggest that METTL14 and YTHDF2 could be potential prognostic biomarkers for Ewing's sarcoma.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Oncology

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

Kezhe Tan et al.

Summary: This study reveals the important role of SMAD9 in neuroblastoma and its positive transcriptional feedback loop with MYCN, representing a unique tumor dependency for MYCN-amplified neuroblastoma.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection

Review Oncology

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

David S. Shulman et al.

Summary: The introduction of dose intensified interval compressed therapy has improved event-free survival for localized Ewing sarcoma patients. However, a significant number of patients still experience relapse and die of the disease, with surviving patients often facing debilitating late effects. Traditional clinical features are inadequate for risk stratification, highlighting the need to develop approaches based on molecular features. New technology has allowed the study of multiple molecular biomarkers in Ewing sarcoma, which may enable risk-adapted treatment in the future.

NPJ PRECISION ONCOLOGY (2022)

Add to Collection

Article Oncology

Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5

Kezhe Tan et al.

Summary: ALKBH5 is closely related to glucose metabolism in neuroblastoma (NB) patients, and a prognostic model has been established to predict the overall survival (OS) of NB patients, which has high application value.

JOURNAL OF CANCER (2022)

Add to Collection

Article Biochemical Research Methods

A drug repositioning algorithm based on a deep autoencoder and adaptive fusion

Peng Chen et al.

Summary: A drug repositioning algorithm based on deep autoencoder and adaptive fusion was proposed in this study to address the issues of decreased precision and low-efficiency multisource data fusion caused by data sparseness. Experimental results showed that the algorithm achieved higher precision and recall rates compared to other existing algorithms, providing an effective auxiliary method for drug repositioning research.

BMC BIOINFORMATICS (2021)

Add to Collection

Review Medicine, General & Internal

Ewing's Sarcoma

Nicolo Riggi et al.

Summary: Ewing's sarcoma is an aggressive cancer that primarily affects children and young adults. In 85 to 90% of cases, a t(11;22) translocation is present. Treatment typically involves surgery, radiotherapy, and chemotherapy, with a 5-year survival rate of around 70%.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Oncology

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis

Oxana Schmidt et al.

Summary: Histone deacetylases (HDACs) class I are continuously expressed in Ewing sarcoma (EwS), with patients having high levels of individual class I HDAC expression showing decreased overall survival. Knockout of HDAC1 and HDAC2 inhibited invasiveness in EwS cells and blocked tumor growth in xenograft mice. Treatment with HDAC inhibitors enhanced susceptibility to chemotherapeutics and mimicked the effects of EZH2 RNAi, suggesting potential for combination therapy in treating this malignant disease.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists

Jialin Mo et al.

Summary: The study identifies FACT inhibition as an effective strategy for overcoming resistance to Smoothened inhibitors and provides preclinical support for initiating clinical trials of the FACT-targeted drug CBL0137 against hedgehog-driven cancers.

CANCER RESEARCH (2021)

Add to Collection

Review Oncology

N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies

Fenghua Tan et al.

Summary: N6-methyladenosine (m6A) modification is a reversible epigenetic modification that regulates the expression levels of mRNA and noncoding RNA by modulating the fate of RNA molecules. Dysregulation of m6A modification, especially in human tumors, affects different signal transduction pathways and is involved in biological processes of tumor cell proliferation, apoptosis, invasion, migration, and metabolic reprogramming.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Advances in targeting 'undruggable' transcription factors with small molecules

Matthew J. Henley et al.

Summary: Transcription factors play important roles in various diseases and recent advancements in chemical biology have provided new possibilities for targeting TFs with small molecules. However, challenges remain, such as addressing structural disorder and finding appropriate targeting strategies.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Article Oncology

The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors

Vera Miranda-Goncalves et al.

Summary: The study found significant differences in the expression of various m(6)A modifiers in cell lines representing different classes of GCTs, as well as changes after treatment with all-trans retinoic acid. Knockdown of VIRMA resulted in disruption of the methyltransferase complex, decreased m(6)A abundance, reduced tumor aggressiveness, and increased sensitivity to cisplatin treatment both in vitro and in vivo. Enhanced response to cisplatin after VIRMA knockdown was associated with increased DNA damage and downregulation of specific genes related to DNA repair.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma

Guillermo Flores et al.

MOLECULAR CANCER THERAPEUTICS (2020)

Add to Collection

Review Oncology

m6A modification in RNA: biogenesis, functions and roles in gliomas

Yuhao Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma

Xianping Shi et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

Sara Sanchez-Molina et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis

Guoqi Li et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Review Cell Biology

EMT Transition States during Tumor Progression and Metastasis

Ievgenia Pastushenko et al.

TRENDS IN CELL BIOLOGY (2019)

Add to Collection

Article Cell Biology

m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas

Rui-Chao Chai et al.

AGING-US (2019)

Add to Collection

Article Oncology

EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins

Paradesi Naidu Gollavilli et al.

CANCER RESEARCH (2018)

Add to Collection

Article Multidisciplinary Sciences

The landscape of genomic alterations across childhood cancers

Susanne N. Groebner et al.

NATURE (2018)

Add to Collection

Article Medicine, General & Internal

Ewing sarcoma

Thomas G. P. Gruenewald et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Add to Collection

Article Multidisciplinary Sciences

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours

Xiaotu Ma et al.

NATURE (2018)

Add to Collection

Article Biochemical Research Methods

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

Julia Joung et al.

NATURE PROTOCOLS (2017)

Add to Collection

Article Multidisciplinary Sciences

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma

Peter Y. Yu et al.

PLOS ONE (2017)

Add to Collection

Article Oncology

Let-7a suppresses macrophage infiltrations and malignant phenotype of Ewing sarcoma via STAT3/NF-κB positive regulatory circuit

Zhongzu Zhang et al.

CANCER LETTERS (2016)

Add to Collection

Article Oncology

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma

Salah-Eddine Lamhamedi-Cherradi et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Oncology

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma

Salah-Eddine Lamhamedi-Cherradi et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Add to Collection

Article Oncology

IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells

Andrej Lissat et al.

BMC CANCER (2015)

Add to Collection

Review Oncology

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

Nathalie Gaspar et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Biotechnology & Applied Microbiology

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Wei Li et al.

GENOME BIOLOGY (2014)

Add to Collection

Article Pathology

NKX2.2 is a Useful Immunohistochemical Marker for Ewing Sarcoma

Akihiko Yoshida et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma

Leah A. Owen et al.

PLOS ONE (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Intrinsic disorder in transcription factors

Jiangang Liu et al.

BIOCHEMISTRY (2006)

Add to Collection

Article Oncology

STAT3 is activated in a subset of the Ewing sarcoma family of tumours

R Lai et al.

JOURNAL OF PATHOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.